The Li–Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube
- 17 September 2009
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 220 (1), 17-23
- https://doi.org/10.1002/path.2624
Abstract
A candidate early precursor to pelvic serous cancer, the ‘p53 signature’, is commonly found in the benign mucosa of the distal Fallopian tube and harbours p53 mutations and evidence of DNA damage. We examined tubes from women with pre‐existing (germ‐line) mutations in p53 [Li–Fraumeni syndrome (LFS)] for evidence of this precursor. Fallopian tubes from two cases of LFS were immunostained for p53, Ki‐67 (proliferation) and H2AX (DNA damage response) and analysed for p53 mutations by laser capture microdissection (LCM) and p53 genomic sequencing (exons 2–11). A common single nucleotide repeat (snp) in exon 3 (rs1042522) and deletion sequencing chromatograms in exon 4 were examined in combination to estimate LOH in both LFS tubes and advanced serous carcinomas from the general population. LFS tubal epithelium contained abundant (10–20 per section) p53 signatures with evidence of DNA damage and low proliferative activity. Six of 11 LFS microdissected p53 signatures (55%) and 15 of 21 serous carcinomas (71%) revealed LOH at the p53 locus, relative to background epithelium. The LFS model confirms prior observations that the distal Fallopian tube is particularly prone to focal epithelial p53 gene inactivation—p53 mutation and LOH—in the absence of malignancy or increased epithelial proliferation. The fact that the LFS is not associated with ovarian cancers is consistent with the concept that loss of p53 function must be accompanied by at least one more genotoxic event (including BRCA1/2 functional inactivation) to produce the malignant phenotype. This is in keeping with a general model of carcinogenesis, in which different and often independent risk factors operate at multiple points in the serous carcinogenic spectrum. Copyright © 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 30 references indexed in Scilit:
- The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a lossGenes & Development, 2008
- A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutationsGynecologic Oncology, 2008
- Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalitiesBMC Cancer, 2008
- Serous Carcinogenesis in the Fallopian TubeInternational Journal of Gynecological Pathology, 2008
- Primary Fallopian Tube Malignancies in BRCA-Positive Women Undergoing Surgery for Ovarian Cancer Risk ReductionJournal of Clinical Oncology, 2007
- p63 Is Essential for the Proliferative Potential of Stem Cells in Stratified EpitheliaCell, 2007
- Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal RelationshipThe American Journal of Surgical Pathology, 2007
- A candidate precursor to serous carcinoma that originates in the distal fallopian tubeThe Journal of Pathology, 2006
- BRCA-Mutation–Associated Fallopian Tube CarcinomaObstetrics & Gynecology, 2005
- The Li-Fraumeni syndrome: An inherited susceptibility to cancerMolecular Medicine Today, 1997